A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates
Rosén, S.
Thrombosis and Haemostasis 86(4): 1132-1133
2001
ISSN/ISBN: 0340-6245 PMID: 11686346 Document Number: 529502
Document emailed within 1 workday
Related Documents
Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832
Brown, J.E.; Carton, C.L.; Hougie, C. 1981: The effect of naturally occurring antibodies to factor VIIi on an immunoradiometric assay for factor VIIi coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIIi inhibit Journal of Laboratory and Clinical Medicine 97(1): 65-71
Allain, J.P. 1972: Study of the "in vivo" activity of factor VIIi or factor IX after injection of several concentrates: practical applications Nouvelle Revue Francaise d'Hematologie 12(2): 241-249
Vicente, V. 1989: Plasma concentrates of factor VIII. Where are we? Sangre 34(1): 1-3
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247
Laurian, Y.; Dussaix, E.; Parquet, A.; Chalvon-Demersay, A.; d'Oiron, R.; Tchernia, G. 1994: Transmission of human parvovirus B19 by plasma derived factor VIIi concentrates Nouvelle Revue Francaise d'Hematologie 36(6): 449-453
Eich, S.; Kusch, M.; Grundmann, C.; Hanker, C.; Seitz, R.; König, H. 2003: Factor VIII determination in patient's plasma and concentrates: a novel test equally suited for both matrices Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 14(4): 347-353
Lee, C.A.; Owens, D.; Bray, G.; Giangrande, P.; Collins, P.; Hay, C.; Gomperts, E.; Schroth, P.; Barrowcliffe, T. 1999: Pharmacokinetics of recombinant factor VIIi (recombinate) using one-stage clotting and chromogenic factor VIIi assay Thrombosis and Haemostasis 82(6): 1644-1647
Elykomov, V.A.; Tsalikhin, A.D. 1991: A uniform technique of one-stage factor VIII:C assay in cryoprecipitate and its concentrates. Part II (according to the results obtained by the group of the "Hemostasis Pathology Commission) Gematologiia i Transfuziologiia 36(11): 31-33
Teitel, J.M.; Lau, H.K.; Garvey, M.B. 2002: Discrepancies in measured factor VIIi activity in patients treated with factor VIIi concentrate of human or porcine origin Thrombosis and Haemostasis 88(1): 159-160
Cumming, A.M.; Wensley, R.T.; Delamore, I.W. 1986: The assay of factor VIII: C in heparinized plasma: a polybrene neutralization method Thrombosis and Haemostasis 55(1): 58-60
Neugebauer, B.M.; Goy, C.; Seitz, R. 2002: A collagen binding assay: an additional method for von Willebrand factor activity in therapeutic concentrates Thrombosis and Haemostasis 88(5): 871-872
Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Klarmann, D.; Kreuz, W.; Auerswald, G.; Auberger, K.; Rabenau, H.; Gürtler, L.; Roggendorf, M. 1995: Hepatitis C and pasteurised factor VIIi and IX concentrates Thrombosis and Haemostasis 73(4): 736-737
Yoshioka, A.; Shima, M.; Nishino, M.; Yoshikawa, N.; Fukui, H. 1987: In vitro characterization of various factor VIII concentrates Arzneimittel-Forschung 37(7): 753-756
Hofmann, V.; Ermanni, M.; Straub, P.W. 1978: Thrombin formation in factor IX concentrates and FEIBA (factor eight inhibitor bypassing activity) (proceedings) Schweizerische Medizinische Wochenschrift 108(41): 1600
James O' Donnell and Michael Laffan 2001: Elevated Plasma Factor VIII Levels - a Novel Risk Factor for Venous Thromboembolism Clinical Laboratory 47(1-2): 1-6
Hernández-Jerónimo, J.; Pérez-Campos, E.; Matadamas, C.ém.; Majluf-Cruz, A. 2003: A new thrombophilia risk factor: the increase of plasma factor VIIi Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 55(4): 448-457